[HTML][HTML] The global impact of COVID-19 on solid organ transplantation: two years into a pandemic
A Nimmo, D Gardiner, I Ushiro-Lumb, R Ravanan… - …, 2022 - journals.lww.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has had a major global
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …
Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research
S Weerakkody, P Arina, J Glenister… - The Lancet …, 2022 - thelancet.com
Non-invasive respiratory support (NIRS) has increasingly been used in the management of
COVID-19-associated acute respiratory failure, but questions remain about the utility, safety …
COVID-19-associated acute respiratory failure, but questions remain about the utility, safety …
[HTML][HTML] Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based …
Background COVID-19 vaccines show excellent efficacy in clinical trials and effectiveness in
real-world data, but some people still become infected with SARS-CoV-2 after vaccination …
real-world data, but some people still become infected with SARS-CoV-2 after vaccination …
Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS …
Importance Continuous positive airway pressure (CPAP) and high-flow nasal oxygen
(HFNO) have been recommended for acute hypoxemic respiratory failure in patients with …
(HFNO) have been recommended for acute hypoxemic respiratory failure in patients with …
Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre …
R Carbonell, S Urgelés, A Rodríguez… - The Lancet Regional …, 2021 - thelancet.com
Background It is unclear whether the changes in critical care throughout the pandemic have
improved the outcomes in coronavirus disease 2019 (COVID-19) patients admitted to the …
improved the outcomes in coronavirus disease 2019 (COVID-19) patients admitted to the …
[HTML][HTML] Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective …
RA Evans, OC Leavy, M Richardson… - The Lancet …, 2022 - thelancet.com
Background No effective pharmacological or non-pharmacological interventions exist for
patients with long COVID. We aimed to describe recovery 1 year after hospital discharge for …
patients with long COVID. We aimed to describe recovery 1 year after hospital discharge for …
[HTML][HTML] Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study
Background Immunocompromised patients may be at higher risk of mortality if hospitalised
with Coronavirus Disease 2019 (COVID-19) compared with immunocompetent patients …
with Coronavirus Disease 2019 (COVID-19) compared with immunocompetent patients …
Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study
Background Acute kidney injury (AKI) is common in coronavirus disease 2019 (COVID-19).
This study investigated adults hospitalized with COVID-19 and hypothesized that risk factors …
This study investigated adults hospitalized with COVID-19 and hypothesized that risk factors …
Author Correction: Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England
The code linked in the Code availability statement in the Article is correct: https://github.
com/mrc-ide/sarscov2-severity-england. The previous incorrect version of the code is …
com/mrc-ide/sarscov2-severity-england. The previous incorrect version of the code is …
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
Rationale In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit of
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …